Clinical Trials in Austin

Showing 9821-9840 of 15,205 trials

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

NCT01682876

This study was designed to conduct a comparative trial to further evaluate the safety, immunogenicity and antibody persistence of two doses of Novartis MenACWY conjugate vaccine, given 2 months apart, versus one dose of Novartis MenACWY conjugate vaccine in children 2 through 10 years of age.

Meningococcal DiseaseInfections, Meningococcal

GlaxoSmithKline715 participantsStarted Oct 2012

Birmingham, Alabama, United States • Sacramento, California, United States • Lake Mary, Florida, United States +16 more locations

COMPLETEDPhase 3< 1 mile

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

NCT02138916

The purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in symptomatic patients with moderate to very severe COPD who are receiving standard of care therapies

Moderate to Very Severe Chronic Obstructive Pulmonary Disease

AstraZeneca1,656 participantsStarted Jun 2014

Andalusia, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +404 more locations

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Find Trials by Condition in Austin

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Indomethacin PK and PD Therapy in Pregnancy

Assessing Superion Clinical Endpoints vs. Decompression

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age